Bob has served as Chairman of the Board at Imagion Biosystems since the company’s IPO in 2017. As President and CEO of Imagion Biosystems beginning in February 2015 until June 2023, he led the company developing the nanoparticle-based medical imaging technology from early proof of concept through initial clinical development until June 2023. Bob’s career spans more than 30 years with experience in the computer, life science and medical diagnostics industries. Mr. Proulx holds an M.A. and B.A. from The State University of New York at Albany and an Executive MBA from the Penn State Smeal College of Business.
Employee Spotlight: Dan Inglese, Research Associate
April 12, 2022
Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems: What experience do you bring prior to joining IB? I